Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
analyte | substance the assay measures | The analyte on the outside report is total phenytoin. | Objective | Drug levels - analyte, specimen and reporting |
analyte identity check | confirming exactly which chemical, drug or metabolite was measured | Complete the analyte identity check before associating the outside result with the new sample. | Plan | Sampling, laboratory verification and communication |
assay cross-reactivity | measurement response to substances other than the intended analyte | The laboratory was asked whether assay cross-reactivity might affect the immunoassay result. | Assessment | Drug concentrations, exposure and assay interpretation |
below-quantitation result | analyte is below the assay's stated range for reliable quantification | The below-quantitation result was preserved with the laboratory's qualifier and units. | Assessment | Medication response, exposure and reconciliation |
biochemical response | change in a measured analyte after an intervention | The biochemical response preceded the improvement in exercise tolerance. | Assessment | Diagnostic reasoning and strength of evidence |
cross-reactant | substance other than the intended analyte recognized by an assay | The laboratory identified a possible cross-reactant in the immunoassay. | Objective | Drug levels - analyte, specimen and reporting |
fosphenytoin | prodrug converted to phenytoin, relevant to level timing and analyte identity | The administration record lists fosphenytoin and the laboratory measured phenytoin. | Objective | Drug levels - named analytes and exposure reports |
mass spectrometry | method identifying or measuring analytes by mass-to-charge ratio | The laboratory measured the drug using liquid chromatography with tandem mass spectrometry. | Objective | Drug levels - analyte, specimen and reporting |
plasma concentration | amount of analyte per volume of plasma | The plasma concentration was reported on the specimen collected yesterday. | Objective | Drug levels - analyte, specimen and reporting |
renal clearance | removal of a drug or analyte by the kidneys | The assessment considers reduced renal clearance after the creatinine increase. | Assessment | Drug levels - exposure and pharmacokinetics |
salicylate | analyte measured in evaluation of salicylate exposure | Two salicylate concentrations are listed with their individual collection times. | Objective | Drug levels - named analytes and exposure reports |
target detected | assay identified the specific sequence or analyte being tested for | The report states "target detected" for one target on the respiratory panel. | Objective | Molecular testing, serology and culture findings |
acetaminophen | analgesic measured in timed exposure assessments when clinically indicated | The acetaminophen concentration is recorded alongside the reported ingestion time. | Objective | Drug levels - named analytes and exposure reports |
active metabolite | metabolic product that has pharmacologic activity | The laboratory measured the active metabolite separately. | Objective | Drug levels - analyte, specimen and reporting |
aliquot volume | amount of specimen separated for analysis | The laboratory documented insufficient aliquot volume for the free level. | Objective | Drug levels - analyte, specimen and reporting |
amended result | laboratory result formally revised after initial reporting | The amended result lists the corrected specimen time. | Objective | Drug levels - analyte, specimen and reporting |
amikacin | aminoglycoside with drug- and regimen-specific concentration targets | The amikacin concentration is documented with the dialysis session time. | Objective | Drug levels - named analytes and exposure reports |
amitriptyline | tricyclic antidepressant with an active nortriptyline metabolite | The amitriptyline result is reported separately from nortriptyline. | Objective | Drug levels - named analytes and exposure reports |
assay interference | another substance or condition alters the measurement | The laboratory appended a comment about possible assay interference. | Objective | Drug levels - analyte, specimen and reporting |
assay method | technique used to obtain a reported concentration | The assay method is specified on the transplant laboratory report. | Objective | Drug levels - analyte, specimen and reporting |
below quantification | present or reported below a reliable numeric reporting limit | The analyte was reported as below quantification without an exact concentration. | Objective | Drug levels - analyte, specimen and reporting |
busulfan | alkylating agent with protocol-specific pharmacokinetic sampling | Each busulfan sample is linked to the actual infusion record. | Objective | Drug levels - named analytes and exposure reports |
calibration curve | relationship between instrument response and known concentration | The laboratory report references the validated calibration curve. | Objective | Drug levels - analyte, specimen and reporting |
| material of known value used to establish assay response | The laboratory repeated analysis after checking the calibrator. | Objective | Drug levels - analyte, specimen and reporting | |
carbamazepine | antiseizure medicine with a separately measurable active epoxide metabolite | The carbamazepine and epoxide measurements appear on separate lines. | Objective | Drug levels - named analytes and exposure reports |